Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Is Ipamorelin Worth It: Peptide Comparison

Choosing the right growth hormone secretagogue depends on whether your research prioritizes receptor selectivity, pulse amplitude, cost efficiency, or multi-pathway hormonal activation. This comparison evaluates Ipamorelin against commonly used alternatives ac

This comparison does not assign a generated winner or score.

  • Choosing the right growth hormone secretagogue depends on whether your research prioritizes receptor selectivity, pulse amplitude, cost efficiency, or multi-pathway hormonal activation. This comparison evaluates Ipamorelin against commonly used alternatives across key research variables.
  • Ipamorelin
  • 2–3× baseline
  • None
  • Minimal
  • ~2 hours
  • Moderate
  • Studies requiring GH isolation from cortisol/prolactin confounds; cognitive aging models; tissue repair with inflammatory marker tracking
  • Worth it when selectivity is a controlled variable; inefficient when raw GH amplitude or cost-per-pulse matters more
  • GHRP-2
  • 3–4× baseline
  • Moderate (20–35% elevation)
  • ~30 minutes
  • Low
  • Metabolic studies where cortisol is not a confounding variable; anabolic research in healthy models
  • Better cost efficiency than Ipamorelin for most anabolic and metabolic research unless cortisol must remain stable
  • GHRP-6
  • 3.5–5× baseline
  • High (40–50% elevation)
  • High
  • Appetite and ghrelin pathway research; models examining GH + ghrelin synergy
  • Produces largest GH response but cortisol and ghrelin elevation confound many study designs
  • Hexarelin
  • 4–6× baseline
  • Moderate to High
  • ~70 minutes
  • Low to Moderate
  • Maximum GH release studies; cardiac function models (GHS-R1a expressed in cardiomyocytes)
  • Highest GH amplitude; useful when off-target receptor activity is research-relevant, not when selectivity is required
  • CJC-1295 (with DAC)
  • Sustained 2–4× baseline over 6–8 days
  • 6–8 days
  • Chronic GH elevation studies; long-duration anabolic or tissue repair protocols
  • Preferred for sustained elevation; expensive per vial but reduces injection frequency and dosing variability
  • Sermorelin
  • ~10 minutes (requires co-administration with secretagogue for synergy)
  • GHRH pathway research; synergistic stacking with Ipamorelin or GHRP compounds
  • Useful only in combination; produces minimal GH response as monotherapy due to short half-life
  • The bottom line: Ipamorelin worth it becomes yes when your protocol cannot tolerate cortisol or prolactin variability. Tissue repair studies tracking inflammatory markers, cognitive research where cortisol is neurotoxic, or receptor-specific mechanistic investigations. It becomes no when GH pulse magnitude or cost efficiency outweigh selectivity. Metabolic lipolysis studies, anabolic muscle research in healthy models, or any application where GHRP-2 or Hexarelin deliver clearer data at 40–60% lower cost per dose.